- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 18-12-2025: Press Release
18-12-2025 | 11:02 am
18-12-2025 | 11:02 am
Alembic Pharma secures USFDA final approval for Travoprost Ophthalmic Solution, used for glaucoma. This opens up a US$ 61 million market opportunity, boosting its strong ANDA portfolio.
No comments yet. Be the first to comment!